Expression of hepatocyte growth factor and c-met in ulcerative colitis

Inflammation Research

Volumn 49, Issue 7, 2000, Pages 320-

  Kitamura, Shinji ^a   Kondo, Shinya ^a,c   Shinomura, Yasuhisa ^a   Isozaki, Kouji ^a   Kanayama, Shuji ^a   Higashimoto, Yoshifumi ^a   Minami, Takeshi ^a   Kiyohara, Tatsuya ^a   Yasunaga, Yuichi ^a   Ishikawa, Hideki ^b   Ohtani, Toru ^b   Ishiguro, Shingo ^b   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c SUMITOMO HOSPITAL   (Japan)

Author keywords

c met; Colorectal cancer; Hepatocyte growth factor; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CHEMISTRY; COLON; COLON TUMOR; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; MALE; METABOLISM; MIDDLE AGED; RECTUM TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MET; RECTAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0034221920     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000212     Document Type: Article

References (25)

1. Lennard-Jones JE, Morson BC, Ritchie JK. Cancer surveillance in ulcerative colitis. Lancet 1983; 2: 149-52.
2. Collins RHJR, Feldman M, Fordtran JS. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 1987; 316: 1654-8.
3. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. N Engl J Med 1990; 323: 1228-33.
4. Korelitz BI. Features of cancer of the colon and rectum complicating ulcerative colitis. In: Bochus Gastroenterology 5th ed. WB Saunders Company, 1995: 1364-73.
5. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-9.
6. Dignass AU, Lynch-Devaney K, Podolsky K. Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biohem Biophys Res Com 1994; 202: 701-9.
7. Takahashi M, Ota S, Shimada T, Hamada E, Kawabe T, Okudaira T, et al. Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation. J Clin Invest 1995; 95: 1994-2003.
8. Tsarfaty I, Resau JH, Rulong S, Keydar I, Faletto DL, Vande Woude GF. The met protooncogene receptor and lumen formation. Science 1992; 257: 1258-61.
9. Kanda H, Tajima H, Lee GH, Nomura K., Ohtake K, Matsumoto K, et al. Hepatocyte growth factor transforms immortalized liver epithelial cells. Oncogene 1993; 8: 3047-53.
10. Prat M, Narsimhan RP, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM. The receptor encoded by the human c-met oncogene is expressed in hepatocyte epithelial cells and solid tumors. Int J Cancer 1991; 49: 323-8.
11. Liu C, Park M, Tsao MS. Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. Oncogene 1992; 7: 181-5.
12. Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, et al. Overexpression and amplification of the Met/HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1995; 1: 147-54.
13. Matts F. The value of rectal biopsy in the diagnosis of ulcerative colitis. Quart J Med 1961; 120: 393-407.
14. Kondo S, Shinomura Y, Kanayama S, Higashimoto Y, Kiyohara T, Yasunaga Y, et al. Helicobacter pylori increases gene expression of hepatocyte growth factor in human gastric mucosa. Biochem Biophys Res Commun 1995; 210: 960-5.
15. L gene in human gastric adenomas and carcinomas. Int J Cancer 1996; 68: 727-30.
16. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988; 81: 414-9.
17. Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992; 103: 1587-95.
18. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, et al. Tumor necrosis factor-α interleukin-1β and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992; 37: 818-26.
19. Tamura, M, Arakaki N., Tsubouchi H, Ttakada H, Daikuhara Y. Enhancement of human hepatocyte growth factor production by interleukin-1α and -1β and tumor necrosis factor-α by fibroblasts in culture. J Biol Chem 1992; 268: 8140-5.
20. Jeffers M, Rong S, Anver M, Vande Woude GF. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastatic phenotype in C127 cells. Oncogene 1996; 13: 853-61.
21. Meltzer SJ, Mane SM, Wood PK, Resau JH, Newkirk C, Terzakis JA, et al. Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products. Cancer Res 1990; 50:3627-30.
22. Tarmin L, Yin J, Harpaz N, Kozam M, Noordzij J, Antonio LB, et al. Adenomatous polyposis coli gene mutations in UC-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 1995; 55: 2035-8.
23. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, et al. Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994; 107: 369-78.
24. Ilyas M, Talbot C. p53 expression in ulcerative colitis: a longitudinal study. Gut 1995; 37: 802-4.
25. Moghul A, Lin L, Beedle A, Kanbour-Shakir A, Defrances MC, Liu Y et al. Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. Oncogene 1994; 9: 2045-52.